477 related articles for article (PubMed ID: 31945396)
1. ASXL1 mutation in clonal hematopoiesis.
Fujino T; Kitamura T
Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
[TBL] [Abstract][Full Text] [Related]
2. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
Asada S; Kitamura T
Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
[TBL] [Abstract][Full Text] [Related]
3. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
Fujino T
Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
[TBL] [Abstract][Full Text] [Related]
4. Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway.
Fujino T; Goyama S; Sugiura Y; Inoue D; Asada S; Yamasaki S; Matsumoto A; Yamaguchi K; Isobe Y; Tsuchiya A; Shikata S; Sato N; Morinaga H; Fukuyama T; Tanaka Y; Fukushima T; Takeda R; Yamamoto K; Honda H; Nishimura EK; Furukawa Y; Shibata T; Abdel-Wahab O; Suematsu M; Kitamura T
Nat Commun; 2021 Mar; 12(1):1826. PubMed ID: 33758188
[TBL] [Abstract][Full Text] [Related]
5. The role of ASXL1 in hematopoiesis and myeloid malignancies.
Asada S; Fujino T; Goyama S; Kitamura T
Cell Mol Life Sci; 2019 Jul; 76(13):2511-2523. PubMed ID: 30927018
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
[TBL] [Abstract][Full Text] [Related]
7. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119.
Köhnke T; Nuno KA; Alder CC; Gars EJ; Phan P; Fan AC; Majeti R
Blood Cancer Discov; 2024 May; 5(3):202-223. PubMed ID: 38359087
[TBL] [Abstract][Full Text] [Related]
8. Role of ASXL1 in hematopoiesis and myeloid diseases.
Gao X; You X; Droin N; Banaszak LG; Churpek J; Padron E; Geissler K; Solary E; Patnaik MM; Zhang J
Exp Hematol; 2022 Nov; 115():14-19. PubMed ID: 36183966
[TBL] [Abstract][Full Text] [Related]
9. Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels.
Inoue D; Matsumoto M; Nagase R; Saika M; Fujino T; Nakayama KI; Kitamura T
Exp Hematol; 2016 Mar; 44(3):172-6.e1. PubMed ID: 26700326
[TBL] [Abstract][Full Text] [Related]
10. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.
Nagase R; Inoue D; Pastore A; Fujino T; Hou HA; Yamasaki N; Goyama S; Saika M; Kanai A; Sera Y; Horikawa S; Ota Y; Asada S; Hayashi Y; Kawabata KC; Takeda R; Tien HF; Honda H; Abdel-Wahab O; Kitamura T
J Exp Med; 2018 Jun; 215(6):1729-1747. PubMed ID: 29643185
[No Abstract] [Full Text] [Related]
11. New Insights from Studies of Clonal Hematopoiesis.
Gibson CJ; Steensma DP
Clin Cancer Res; 2018 Oct; 24(19):4633-4642. PubMed ID: 29703819
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis in cancer.
Park SJ; Bejar R
Exp Hematol; 2020 Mar; 83():105-112. PubMed ID: 32044376
[TBL] [Abstract][Full Text] [Related]
13. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
14. [Role of ASXL1 mutation in myeloid malignancies].
Sheng MY; Zhou Y; Xu MJ; Yang FC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis, aging, and cardiovascular diseases.
Pardali E; Dimmeler S; Zeiher AM; Rieger MA
Exp Hematol; 2020 Mar; 83():95-104. PubMed ID: 31891750
[TBL] [Abstract][Full Text] [Related]
16. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
Hartmann L; Metzeler KH
Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
[TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
Desai P; Hassane D; Roboz GJ
Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
[TBL] [Abstract][Full Text] [Related]
18. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ
Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594
[TBL] [Abstract][Full Text] [Related]
19. Compartment-specific mutational landscape of clonal hematopoiesis.
Hartmann L; Hecker JS; Rothenberg-Thurley M; Rivière J; Jentzsch M; Ksienzyk B; Buck MC; van der Garde M; Fischer L; Winter S; Rauner M; Tsourdi E; Weidner H; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Lützner J; Goralski S; Bassermann F; Spiekermann K; Hofbauer LC; Schwind S; Platzbecker U; Götze KS; Metzeler KH
Leukemia; 2022 Nov; 36(11):2647-2655. PubMed ID: 36131041
[TBL] [Abstract][Full Text] [Related]
20. Causes and consequences of clonal hematopoiesis.
Weeks LD; Ebert BL
Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]